|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.140 GBX | +0.66% |
|
-5.54% | -37.66% |
| 05-05 | Shield Therapeutics plc, Q1 2026 Sales/ Trading Statement Call, May 05, 2026 | |
| 05-01 | EARNINGS AND TRADING: ProService Building Services lowers outlook | AN |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Stocks
- STX Stock
- Consensus Shield Therapeutics plc
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
